ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

PRTC PureTech Health PLC

28.4708
0.5008 (1.79%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
PureTech Health PLC PRTC NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.5008 1.79% 28.4708 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
28.07 27.69 28.4708 28.4708 27.97
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202404:22BWPureTech Announces Annual Results for Year Ended December..
18/4/202401:00BWPureTech Health: Notice of Results
16/4/202406:00BWPureTech Announces Completion of Enrollment in Phase 2b..
11/4/202406:00BWPureTech Receives FDA Fast Track Designation for LYT-200 in..
09/4/202401:00BWPureTech Launches Seaport Therapeutics with $100 Million..
19/3/202402:00BWPureTech Proposes $100 Million Capital Return
18/3/202408:52BWBristol Myers Squibb Completes Acquisition of PureTech's..
13/3/202406:00BWPureTech Receives Orphan Drug Designation for LYT-200 in..
27/2/202406:00BWPureTech to Present at Two Upcoming Investor Conferences
27/2/202401:00BWPureTech Founded Entity Akili Announces Positive Results..
04/1/202415:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202406:00BWPureTech to Present at 42nd Annual J.P. Morgan Healthcare..
22/12/202308:13BWPureTech Founded Entity Karuna Therapeutics to be Acquired..
20/12/202301:00BWPureTech Year End Update and Outlook for 2024
07/12/202305:00BWPureTech Presents Data from Phase 1 Trial of LYT-200..
29/11/202309:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
17/11/202301:00BWPureTech Founded Entity Karuna Therapeutics Announces..
14/11/202301:00BWPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary..
02/11/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/10/202301:00BWPureTech to Present at Two Upcoming Investor Conferences
11/10/202306:00BWPureTech Presents Data from LYT-100 (Deupirfenidone) Trial..
04/10/202306:05BWPureTech Founded Entity Vedanta Biosciences Announces First..
28/9/202306:38BWKarXT, invented at PureTech, submitted for FDA Approval in..
27/9/202301:05BWPureTech Announces the Appointment of Robert Lyne as Chief..
06/9/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202305:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202301:00BWPureTech Health plc – Half-Year Report
22/8/202301:00BWPureTech Health: Notice of Half-Yearly Results
02/8/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/8/202306:00BWPureTech Awarded up to $11.4 Million from U.S. Department of..
06/7/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/6/202306:00BWPureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral..
13/6/202311:40BWResults of PureTech's Annual General Meeting
24/5/202306:00BW PureTech to Present at the Jefferies Healthcare Conference
09/5/202301:00BWPureTech Founded Entity Vedanta Biosciences Receives Fast..

Su Consulta Reciente

Delayed Upgrade Clock